Regulatory actions for Aug. 5, 2026Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Allergan, Cervomed, Cortechs.ai, Fresenius, Galaxy, Innocare, Sanofi, Xellsmart.